| Literature DB >> 27742110 |
Travis C Salzillo1, Jingzhe Hu2, Linda Nguyen3, Nicholas Whiting4, Jaehyuk Lee4, Joseph Weygand1, Prasanta Dutta4, Shivanand Pudakalakatti4, Niki Zacharias Millward4, Seth T Gammon4, Frederick F Lang5, Amy B Heimberger5, Pratip K Bhattacharya6.
Abstract
This article reviews existing and emerging techniques of interrogating metabolism in brain cancer from well-established proton magnetic resonance spectroscopy to the promising hyperpolarized metabolic imaging and chemical exchange saturation transfer and emerging techniques of imaging inflammation. Some of these techniques are at an early stage of development and clinical trials are in progress in patients to establish the clinical efficacy. It is likely that in vivo metabolomics and metabolic imaging is the next frontier in brain cancer diagnosis and assessing therapeutic efficacy; with the combined knowledge of genomics and proteomics a complete understanding of tumorigenesis in brain might be achieved.Entities:
Keywords: CEST; DNP; GC/MS; Hyperpolarization; MRI; MRS; Metabolic imaging; NMR
Mesh:
Year: 2016 PMID: 27742110 PMCID: PMC5091807 DOI: 10.1016/j.mric.2016.07.003
Source DB: PubMed Journal: Magn Reson Imaging Clin N Am ISSN: 1064-9689 Impact factor: 2.266